OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Authors Task Force Members, Lars Rydén, Peter J. Grant, et al.
European Heart Journal (2013) Vol. 34, Iss. 39, pp. 3035-3087
Open Access | Times Cited: 1861

Showing 26-50 of 1861 citing articles:

Molecular mechanisms of ROS production and oxidative stress in diabetes
Philip Newsholme, Vinícius Fernandes Cruzat, Kevin N. Keane, et al.
Biochemical Journal (2016) Vol. 473, Iss. 24, pp. 4527-4550
Open Access | Times Cited: 747

The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation
Charalambos Vlachopoulos, Panagiotis Xaplanteris, Victor Aboyans, et al.
Atherosclerosis (2015) Vol. 241, Iss. 2, pp. 507-532
Open Access | Times Cited: 657

Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
Vera Regitz‐Zagrosek, Sabine Oertelt‐Prigione, Eva Prescott, et al.
European Heart Journal (2015) Vol. 37, Iss. 1, pp. 24-34
Open Access | Times Cited: 644

The 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in Collaboration With the European Society for Vascular Surgery (ESVS)
Alison Halliday, Jeroen J. Bax
European Journal of Vascular and Endovascular Surgery (2018) Vol. 55, Iss. 3, pp. 301-302
Open Access | Times Cited: 629

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
Petar Seferović, Mark C. Petrie, Gerasimos Filippatos, et al.
European Journal of Heart Failure (2018) Vol. 20, Iss. 5, pp. 853-872
Open Access | Times Cited: 587

Heart failure
Marco Metra, John R. Teerlink
The Lancet (2017) Vol. 390, Iss. 10106, pp. 1981-1995
Closed Access | Times Cited: 562

ATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
A.K.F. Faludi, Maria Cristina de Oliveira Izar, JFK Saraiva, et al.
Arquivos Brasileiros de Cardiologia (2017) Vol. 109, Iss. 1
Open Access | Times Cited: 508

Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes
Petar Seferović, Walter J. Paulus
European Heart Journal (2015) Vol. 36, Iss. 27, pp. 1718-1727
Open Access | Times Cited: 484

Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
Sven Francque, Denise van der Graaff, Wilhelmus J. Kwanten
Journal of Hepatology (2016) Vol. 65, Iss. 2, pp. 425-443
Open Access | Times Cited: 481

Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
Peter Gæde, Jens Oellgaard, Bendix Carstensen, et al.
Diabetologia (2016) Vol. 59, Iss. 11, pp. 2298-2307
Open Access | Times Cited: 460

2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Marco Roffi, Carlo Patrono, Jean‐Philippe Collet, et al.
Kardiologia Polska (2015) Vol. 73, Iss. 12, pp. 1207-1294
Open Access | Times Cited: 458

Diabetic dyslipidemia
WU Li-ya, Klaus G. Parhofer
Metabolism (2014) Vol. 63, Iss. 12, pp. 1469-1479
Closed Access | Times Cited: 451

2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo Piepoli, Arno W. Hoes, Stefan Agewall, et al.
Atherosclerosis (2016) Vol. 252, pp. 207-274
Open Access | Times Cited: 450

2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz, et al.
Blood Pressure (2013) Vol. 22, Iss. 4, pp. 193-278
Open Access | Times Cited: 425

2014 ESC/ESA Guidelines on non-cardiac surgery
Steen Dalby Kristensen, Juhani Knuuti, Antti Saraste, et al.
European Journal of Anaesthesiology (2014) Vol. 31, Iss. 10, pp. 517-573
Open Access | Times Cited: 402

Adherence to diabetes medication: a systematic review
Ines Krass, P. Schieback, Teerapon Dhippayom
Diabetic Medicine (2014) Vol. 32, Iss. 6, pp. 725-737
Closed Access | Times Cited: 400

SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
Silvio E. Inzucchi, Bernard Zinman, Christoph Wanner, et al.
Diabetes and Vascular Disease Research (2015) Vol. 12, Iss. 2, pp. 90-100
Open Access | Times Cited: 385

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Journal of Preventive Cardiology (2021) Vol. 29, Iss. 1, pp. 5-115
Open Access | Times Cited: 370

Exercise training modalities in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis
Bei Pan, Long Ge, Yangqin Xun, et al.
International Journal of Behavioral Nutrition and Physical Activity (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 365

Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
Dalton Bertolim Précoma, Gláucia Maria Moraes de Oliveira, Antônio Felipe Simão, et al.
Arquivos Brasileiros de Cardiologia (2019)
Open Access | Times Cited: 355

2014 ESC/EACTS Guidelines on myocardial revascularization
Stephan Windecker, Philippe Kolh, Fernándo Alfonso, et al.
Kardiologia Polska (2014) Vol. 72, Iss. 12, pp. 1253-1379
Closed Access | Times Cited: 343

Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction
Søren Lund Kristensen, David Preiss, Pardeep S. Jhund, et al.
Circulation Heart Failure (2016) Vol. 9, Iss. 1
Open Access | Times Cited: 337

Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis
Kåre I. Birkeland, Marit E. Jørgensen, Bendix Carstensen, et al.
The Lancet Diabetes & Endocrinology (2017) Vol. 5, Iss. 9, pp. 709-717
Closed Access | Times Cited: 332

Scroll to top